gp41-based peptide vaccine (Merck & Co)

N/A

Report date: 2026/01/23 11:09:09

Base Information

Drug Namegp41-based peptide vaccine (Merck & Co)

Drug Alias NameN-heptad repeat peptide vaccine (Merck & Co)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionTransmembrane glycoprotein gp41 modulators

TargetsTransmembrane glycoprotein gp41

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck & Co Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A